227 related articles for article (PubMed ID: 34624413)
1. Disparities in nonmelanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size: A multicenter retrospective study.
Blumenthal LY; Arzeno J; Syder N; Rabi S; Huang M; Castellanos E; Tran P; Pickering TA; Dantus EJ; In GK; Soriano T; Hu JC
J Am Acad Dermatol; 2022 Feb; 86(2):353-358. PubMed ID: 34624413
[TBL] [Abstract][Full Text] [Related]
2. Response to "Comment on 'Disparities in nonmelanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size: A multicenter retrospective study'".
Blumenthal LY; Hu JC
J Am Acad Dermatol; 2022 Oct; 87(4):e127-e128. PubMed ID: 35662660
[No Abstract] [Full Text] [Related]
3. Comment on "Disparities in nonmelanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size: A multicenter retrospective study".
Carrasquillo OY; Lambert J; Merritt BG
J Am Acad Dermatol; 2022 Oct; 87(4):e129-e130. PubMed ID: 35671885
[No Abstract] [Full Text] [Related]
4. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
[TBL] [Abstract][Full Text] [Related]
5. Racial and ethnic disparities in basal cell carcinoma treated by Mohs micrographic surgery: the Columbia experience.
Donelian A; Liu Z; Trager MH; Momen-Heravi F; Samie FH
Arch Dermatol Res; 2024 May; 316(5):151. PubMed ID: 38734798
[No Abstract] [Full Text] [Related]
6. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
7. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
[TBL] [Abstract][Full Text] [Related]
9. Nonmelanoma skin cancer and utilization of Mohs micrographic surgery in Medicaid patients.
Sharma AN; Shwe S; Kincaid C; Elsanadi R; Sangar S; Kraus C; Lee PK; Elsensohn A
J Am Acad Dermatol; 2023 Jul; 89(1):e51-e52. PubMed ID: 36870368
[No Abstract] [Full Text] [Related]
10. Mohs Micrographic Surgery for Primary Versus Recurrent or Incompletely Excised Facial High-risk Basal Cell Carcinomas.
Ceder H; Grönberg M; Paoli J
Acta Derm Venereol; 2021 Feb; 101(2):adv00381. PubMed ID: 33205823
[TBL] [Abstract][Full Text] [Related]
11. Characterizing basal cell carcinoma in Hispanic individuals undergoing Mohs micrographic surgery: a 7-year retrospective review at an academic institution in the Bronx.
Soliman YS; Mieczkowska K; Zhu TR; Hossain O; Zhu TH; Ciocon DH; Williams RF
Br J Dermatol; 2022 Oct; 187(4):597-599. PubMed ID: 35442518
[No Abstract] [Full Text] [Related]
12. Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.
Duffy KL; McKenna JK; Hadley ML; Tristani-Firouzi P
Dermatol Surg; 2009 Jan; 35(1):30-3. PubMed ID: 19018813
[TBL] [Abstract][Full Text] [Related]
13. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
14. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
15. Predictors of patient satisfaction with Mohs micrographic surgery at time of surgery and 3 months postsurgery: A prospective cohort study.
Thompson KG; Manoharan D; Tripathi R; Rizk E; Lai J; Carpenter J; Gage D; Jilani S; Lin S; Bibee KP; Scott JF
J Am Acad Dermatol; 2023 Nov; 89(5):992-1000. PubMed ID: 37422015
[TBL] [Abstract][Full Text] [Related]
16. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
17. Clinical factors influencing periocular surgical defects after Mohs micrographic surgery.
Carter KD; Nerad JA; Whitaker DC
Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):83-91. PubMed ID: 10189634
[TBL] [Abstract][Full Text] [Related]
18. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
Lane JE; Kent DE
Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
[TBL] [Abstract][Full Text] [Related]
19. Mohs micrographic surgery and dermatopathology concordance: An analysis of 1421 Mohs cases over 17 years.
Kesty K; Sangueza OP; Leshin B; Albertini JG
J Am Acad Dermatol; 2023 Jan; 88(1):118-122. PubMed ID: 29246825
[TBL] [Abstract][Full Text] [Related]
20. Horizontal histological sections in the preliminary evaluation of basal cell carcinoma submitted to Mohs micrographic surgery.
Portela PS; Teixeira DA; Machado CDAS; Pinhal MAS; Paschoal FM
An Bras Dermatol; 2019; 94(6):671-676. PubMed ID: 31789269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]